Fenazil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenazil

Quick Facts

Property Description
Active ingredient Promethazine hydrochloride
Forms Tablets, Syrup, Rectal Suppositories, Injection
Pharmacological class First-generation H1 receptor antagonist
Common uses (General) Allergy relief, Anti-nausea/anti-vomiting, Sedation
Origin Synthetic (Phenothiazine derivative)

What is Fenazil and What Type of Drug is it?

Fenazil is the trade name for a medication whose sole active ingredient is Promethazine hydrochloride, a potent synthetic chemical entity derived from the phenothiazine chemical structure. Pharmacologically, it is defined as a first-generation H1 receptor antagonist, which is the technical classification for a systemic antihistamine. The inclusion of Promethazine in this class identifies it as a compound that primarily works by blocking the effects of histamine throughout the body.

The classification as a first-generation agent means that, unlike newer anti-allergy medications, Promethazine readily enters the central nervous system. This structural feature is responsible for its dual therapeutic identity, distinguishing it from non-sedating alternatives, as it possesses strong central nervous system effects, namely pronounced sedative effects and significant anticholinergic properties. This dual activity is characteristic of the compound, lending it unique utility beyond standard allergy management.

Fenazil Composition and Available Forms

Fenazil is a single-active ingredient product available in several forms, including tablets for oral use, a syrup (oral solution), rectal suppositories, and a solution for injection intended for parenteral administration. Its composition is limited to the Promethazine hydrochloride active compound, supported by various aqueous-based or solid excipients depending on the final preparation.

The availability across multiple physical forms and routes of administration is a key differentiating factor for Promethazine compared to many other antihistamines. For instance, the availability of both syrup and rectal suppositories ensures the medication can be administered flexibly. Multiple forms of the drug are manufactured, including injection, syrup, and tablets.

What is the General Purpose of Promethazine?

The general therapeutic purpose of Promethazine is to alleviate symptoms associated with allergic conditions, control nausea and vomiting, and provide significant sedation. Its efficacy is rooted in its ability to inhibit histamine activity and suppress the brain's control centers for balance and vomiting reflexes.

This compound’s broad action profile means it is generally used to manage multiple discomforts simultaneously, such as severe restlessness or motion sickness, where its powerful antiemetic effects and sedative capacity are utilized to promote patient comfort and control symptoms. This profile allows for relief in challenging scenarios, distinguishing its role from antihistamines used solely for seasonal allergies.

Regulatory References

  1. NIH LiverTox
  2. NIH MedlinePlus

What side effects are possible with Fenazil?

Possible Side Effects and Safety Information

The safety profile for Promethazine, the active ingredient in Fenazil, is characterized by its effects on the central nervous system (CNS) and its anticholinergic properties, as documented in official regulatory labeling.

Common and Expected Adverse Reactions

The most frequently reported adverse reactions are related to the CNS, including drowsiness and dizziness, which are classified as common in regulatory documents. Other expected effects associated with its mechanism include anticholinergic manifestations such as dry mouth, blurred vision, and urinary retention. System-organ classes affected also include Gastrointestinal Disorders and Dermatological Disorders, the latter noting risks like photosensitivity, requiring avoidance of sun exposure during treatment.

Serious Adverse Reactions and Regulatory Warnings

Official labeling contains specific warnings for rare but severe events. The risk of Fatal Respiratory Depression results in an absolute contraindication for use in pediatric patients under two years of age. Serious hematological reactions, such as agranulocytosis (severe blood disorder), have been reported rarely. For the injection form, a high-level warning exists regarding the risk of Severe Tissue Injury and Gangrene, necessitating caution regarding the injection route.

Population-Specific Safety Constraints

The medication is contraindicated in patients who are in a comatose state. Specific caution is required when prescribing Fenazil to older adults due to their increased susceptibility to severe sedation and confusion. Use is also restricted in individuals with compromised respiratory function or conditions that may be worsened by anticholinergic effects, such as narrow-angle glaucoma.

Overdose and Emergency Response

The official regulatory description of Fenazil (promethazine hydrochloride) overdose covers a wide range of manifestations and severe, life-threatening outcomes.

Documented Overdose Presentations and Risks

Overdose can affect the Central Nervous System, presenting with symptoms ranging from profound Drowsiness and Coma to paradoxical states of Excitation, Hallucinations, and Convulsive seizures. Anticholinergic signs, such as Dilated pupils and Urinary retention, are also documented manifestations.

Severe, life-threatening risks include Fatal respiratory depression and Apnea, as well as Serious ventricular arrhythmias. The potentially fatal Neuroleptic Malignant Syndrome (NMS) has also been reported in association with the drug. The official label notes that excessively large dosages in pediatric patients may cause sudden death.

Required Emergency Actions

The official labeling mandates that individuals suspecting an overdose must Call the local emergency number or the Poison Control Center immediately. Urgent medical attention is required for individuals who experience heart rhythm irregularities or seizures, as these symptoms carry the highest risk for serious outcomes.

Treatment of overdose is intensive symptomatic and supportive, as no specific antidote is known. Regulatory documents caution against using Epinephrine to treat hypotension associated with promethazine overdose, due to the potential for reversal of its vasopressor effects.

Therapeutic Uses of Fenazil

What Fenazil Treats: Main Uses and Benefits

Fenazil is commonly used across therapeutic domains where short-term, supportive symptom management is appropriate, helping to address groups of symptoms that can appear suddenly or intensify over time and create noticeable interference with daily stability. The medication is relevant in contexts involving heightened systemic burden and is used across domains where additional symptomatic support is needed, addressing allergy, nausea, and rest. It provides support that helps ease the overall symptom burden during difficult episodes.

Key Therapeutic Applications

Fenazil is generally applicable within clinical settings that involve acute or disruptive symptom patterns, and is relevant for easing challenging manifestations related to allergic conditions, managing nausea and vomiting (including motion sickness), and assisting with sedation to promote rest and manage pre-procedural apprehension.

“The medication is used to help address physical discomfort, such as itching or nausea, while also assisting in managing distress and supporting rest.”

Detailed Symptom Relief

This medication is commonly used across conditions presenting with acute episodes. For example, it is used for managing the associated cluster of allergy symptoms including itching, sneezing, runny nose, and localized swelling. It is also applied in addressing active nausea and vomiting associated with procedures or travel, and in easing general restlessness before medical procedures.

Quick Fact: Relief for Acute Discomfort
Areas of Symptom Management Symptom management across three domains: allergy, nausea/vomiting, and sedation.
Situational Use Applied during phases of increased distress, such as before travel or post-procedure.
Patient Benefit Contributes to easing the overall symptom load during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility and Non-Eligibility Rules

Fenazil (promethazine) eligibility is strictly defined by regulatory documents, which establish absolute prohibitions and conditional use requirements across several populations and health conditions.

Contraindicated Populations

Official labeling mandates that the medicine must not be used in the following groups:

  • Pediatric patients less than two (2) years of age: This is an absolute contraindication, often marked by a Boxed Warning, due to the potential for fatal respiratory depression.
  • Individuals in a comatose state or experiencing severe Central Nervous System (CNS) depression.
  • Patients with lower respiratory tract symptoms, including asthma, or hypersensitivity to promethazine, other phenothiazines, or any component of the formulation.
  • The use of intra-arterial or subcutaneous injection is also contraindicated due to the risk of tissue damage.

Populations Requiring Caution or Restriction

Use is subject to caution or restriction in patients with specific conditions, primarily due to the drug's anticholinergic and sedative effects:

  • Older Adults (65 years and older): Use with caution is necessary due to increased susceptibility to confusion and severe drowsiness.
  • Hepatic Impairment: Caution is advised in patients with impaired liver function.
  • Comorbidities: Caution is required in patients with narrow-angle glaucoma, prostatic hypertrophy, seizure disorders, or cardiovascular disease.
  • Pregnancy/Lactation: Use is not recommended during the late third trimester of pregnancy or in breastfeeding mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fenazil (promethazine) has officially documented interaction patterns primarily involving pharmacodynamic and pharmacokinetic mechanisms.

A formal contraindication exists for co-administration with Monoamine Oxidase Inhibitors (MAOIs), including use within 14 days of discontinuing an MAOI, due to the risk of intensified central nervous system (CNS) and anticholinergic effects. Furthermore, Epinephrine is contraindicated for treating hypotension during a Fenazil overdose because of the drug's alpha-adrenergic blocking activity.

Pharmacodynamic Interactions are the most significant, where Fenazil increases or prolongs the effect of other CNS depressants, such as alcohol, opioids, barbiturates, and sedatives. This includes a warning that concomitant use significantly enhances the sedative effect and may increase impairment. Co-administration with other anticholinergic agents carries the risk of potentiated effects. Additive hypotensive effects may also occur when used with antihypertensive agents.

Regarding Pharmacokinetic Interactions, official labeling notes that Fenazil is a potential CYP2D6 inhibitor. This interaction can lead to an increase in the plasma concentration (exposure) of co-administered medicines that are CYP2D6 substrates, including Tricyclic Antidepressants (TCAs) and Bupropion. Separately, a time-based restriction requires the drug to be discontinued at least 48 hours before and not resumed for 24 hours following a procedure involving Metrizamide.

Mechanism of Action

Fenazil is a derivative of phenothiazine with a multifaceted antagonism profile. The drug primarily acts as a competitive, non-selective antagonist at the Histamine H1 receptor in both peripheral tissues and the central nervous system (CNS). By blocking H1 receptors, it prevents the downstream signaling cascade typically mediated by histamine binding, modulating cellular excitability and vascular permeability.

Simultaneously, the molecule crosses the blood-brain barrier readily and functions as an antagonist at several other key biological targets. These include post-synaptic mesolimbic Dopamine D2 receptors, contributing to CNS depressant effects. Fenazil also exhibits significant antagonism at muscarinic acetylcholine receptors and alpha-1 adrenergic receptors.

The inhibition of these various G-protein coupled receptors leads to widespread modulation of neurotransmission and cellular processes. Systemically, this poly-antagonism results in altered autonomic outflow and diminished neuronal signaling across multiple central and peripheral regulatory pathways.

Dosage and Administration Information

Fenazil (promethazine hydrochloride) is administered through several established routes of administration, including oral forms (tablets and syrup), rectal suppositories, and parenteral injection. The oral forms may be taken with food, water, or milk to mitigate potential gastrointestinal discomfort.

Dosage and Frequency Principles

Administration is generally intended for short-term, acute symptom management. The specific dosage and frequency depend on the usage scenario. For allergy relief, dosing may be 25 mg once daily at bedtime or a lower dose, such as 12.5 mg, in divided doses taken three times daily. For anti-nausea and vomiting treatment, an initial dose of 25 mg may be followed by 12.5 mg to 25 mg repeated every 4 to 6 hours, as needed. The lowest effective dose should be used for all applications.

Parenteral Administration and Special Conditions

Injection is administered via deep intramuscular (IM) injection, which is the preferred parenteral method. Intravenous (IV) administration is subject to strict protocols and should only be performed after dilution to a concentration not exceeding 25 mg/mL. The IV injection must be administered slowly, at a rate not greater than 25 mg/minute, and must be given into a large, patent vein. Administration via subcutaneous or intra-arterial routes is explicitly prohibited.

Population-Specific Rules

Promethazine is contraindicated for use in pediatric patients under two years of age. For children aged two years and older, the dosage is calculated based on body weight, with the dose adjusted to the minimum effective amount required to manage the symptoms.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus and Basis

Research has explored the drug's mechanism, suggesting it affects the X pathway, which may be involved in inflammation and pain signaling. The drug was utilized in studies based on its X-pathway classification.


Efficacy and Outcomes Research

Research has evaluated whether the combination is associated with changes in patient mobility and stiffness. Clinical trials reported a change in flare-up frequency over a 12-week period.

  • Phase 3 Trials: Major trials examined the drug's use in patients with Y condition. These trials described outcomes across various standardized scales for pain and inflammation. Research findings describe outcomes for all stages of Y condition. Studies also included older adults.
  • Comparative Research: One meta-analysis examined a comparison of the drug to traditional therapies. The analysis reported on changes in patient-reported quality of life measures in both groups.

Administration and Safety Studies

Studies included various schedules of administration within their design. The research design investigated various dosing schedules across patient populations.

  • Discontinuation: Studies explored whether sudden treatment discontinuation was associated with a rebound effect. Researchers observed the frequency of Y condition symptoms in participants who ceased treatment.
  • Long-term Safety: Research has examined the treatment and whether it is associated with long-term joint damage. Research has explored the drug's effect on individuals with a history of heart problems and has investigated whether it is associated with cardiovascular risk. Clinical trials documented adverse event data, including specific frequencies of occurrence.

Important Note

The information presented here is a description of the research studies conducted. This content is not a source of medical advice. Interpretation of these findings and determination of clinical suitability should be made by a qualified healthcare professional.

Key Studies & References

  1. Clinical Guideline for the Management of Y Condition in Adults (2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Fenazil (FAQ)

Q: How quickly does Fenazil typically start to work after the first dose?

According to the official clinical pharmacology information, the effects following oral administration (tablets or syrup) are generally observed within 20 minutes after taking a dose.

Q: What is the difference between Fenazil and other similar medications?

Fenazil belongs to a class of medicines called first-generation H1 receptor antagonists. According to official sources, it differs from many newer antihistamines because it easily enters the brain, which leads to pronounced sedative and anticholinergic effects. This dual activity contributes to its broad utility beyond simple allergy relief.

Q: Why is Fenazil sometimes prescribed for conditions that are not its main indicated use?

Regulatory documents describe Fenazil as having multiple properties, including antihistaminic, sedative, anti-nausea, and anti-motion sickness effects. This broad set of actions means the drug has therapeutic utility for managing various related conditions beyond just its primary purpose.

Q: Is it safe to consume alcohol while taking Fenazil?

Official product information states that concomitant use with alcohol is strongly cautioned against. This is because the medication may increase or intensify the sedating effects of alcohol, as it is a central nervous system depressant.

Q: Does Fenazil interact with common over-the-counter pain relievers like ibuprofen?

Official sources indicate that Fenazil is generally described as safe to take alongside common over-the-counter pain relievers such as paracetamol or ibuprofen. However, it is important to confirm that the pain reliever does not already contain promethazine or a similar sedative ingredient, as this could enhance effects.

Q: Are there any specific foods, drinks, or supplements that must be avoided when taking Fenazil?

The consumption of alcohol is strongly cautioned against due to the risk of increased sedation. Furthermore, official sources advise caution with certain herbal remedies and supplements, especially those known to cause side effects such as sleepiness or dry mouth.

Q: How long do initial side effects from Fenazil usually last?

Side effects can vary by individual, but the most common side effect, drowsiness, is typically resolved within 12 hours of administration, though individual experiences may vary.

Q: What are the signs of a more serious adverse reaction to Fenazil?

Serious reactions can be indicated by signs such as wheezing or difficulty breathing, severe confusion, or uncontrolled body movements. Official warnings also include the potential for unusual bruising or bleeding and yellowing of the skin or eyes, which may indicate liver issues.

Q: Is Fenazil known to cause changes in weight (gain or loss)?

Weight gain has been reported in association with the use of promethazine, the active ingredient in Fenazil.

Q: Can Fenazil affect a person's ability to drive or operate machinery?

Yes, the official information for patients includes warnings that Fenazil may cause marked drowsiness and impair the mental and physical abilities. The label cautions against performing potentially hazardous tasks such as driving a vehicle or operating machinery during treatment.

Q: Does Fenazil have any known interactions with birth control pills?

Official sources state that Fenazil does not affect the effectiveness of any type of hormonal contraception. This includes both the combined pill and emergency contraception.

Q: Is Fenazil considered a controlled substance?

Standalone Fenazil (Promethazine hydrochloride) is not considered a controlled substance. However, official regulatory bodies classify formulations that contain promethazine combined with a narcotic, such as codeine, as Schedule V controlled substances.

Q: What is the average duration of action for a single dose of Fenazil?

The clinical effects from a single dose typically last for four to six hours. However, the effects may persist in the body for as long as 12 hours in some individuals.

Q: Does Fenazil affect mood or cause emotional changes?

Regulatory information notes that Fenazil can potentially cause side effects related to mood and behavior. These have included feelings of nervousness or restlessness, hyperactivity, nightmares, and, in rare instances, an abnormally happy mood or hallucinations.

Q: Is Fenazil safe for use by older adults (seniors)?

Use of Fenazil in older adults requires regulatory caution. This is because seniors may be more susceptible to side effects like confusion and severe drowsiness than younger adults.

Q: What warnings exist for people with pre-existing kidney or liver conditions?

Regulatory information specifically advises caution for patients with impaired liver function. Additionally, official guidance states that the medication requires caution in individuals with pre-existing conditions such as cardiovascular disease or respiratory impairment.

Q: What does the research evidence say about the effectiveness of Fenazil?

Studies and official information indicate that Fenazil is utilized for and studied in relation to its designated purposes. This includes treatment for nausea and vomiting, as well as providing preventative therapy for motion sickness and managing allergy symptoms.

Q: Can a patient stop taking Fenazil suddenly?

When the drug has been used for a long time, there are reports that stopping treatment suddenly may be associated with symptoms like rebound insomnia (difficulty sleeping). Due to the potential for such rebound effects, discontinuation after long-term use is a clinical consideration.

Q: Are there any reported long-term effects associated with Fenazil use?

Official warnings note that the prolonged administration of phenothiazines, the class of drugs Fenazil is derived from, may potentially lead to a movement disorder called tardive dyskinesia.

Q: Can Fenazil be taken at the same time as other daily prescription medications?

Fenazil is not compatible with all prescription medications due to interaction risks. Concomitant use with CNS depressants (medicines that slow brain activity) and certain anticholinergics is subject to strict caution, as these combinations are known to potentially intensify effects.

Q: What happens to the Fenazil in the body after it has been fully absorbed?

Once absorbed, Fenazil is primarily metabolized (broken down) by the liver into various inactive compounds. These breakdown products are then typically excreted from the body, primarily appearing in the urine.

Q: Are there any known differences in effect based on the patient’s age or gender?

Differences in effect based on age are noted in official documents. For example, older adults are more susceptible to sedation, while children may experience paradoxical excitation (increased activity). No specific difference based on gender is explicitly stated in the documentation.

Q: Can Fenazil cause changes in blood pressure or heart rate?

Changes in blood pressure, including both increases and decreases, have been reported in association with Fenazil use. Alterations in heart rate, such as tachycardia (fast heart rate) or bradycardia (slow heart rate), have also been reported.

Q: Is there a maximum amount of time Fenazil is generally safe to use?

According to official information, the drug is generally intended for short-term use for symptom relief. This is because the full risk potential of long-term therapy has not been completely studied in clinical settings.

Q: Are there common signs that indicate Fenazil is actually working?

The most common signs that the medication is working relate directly to its designated uses. This includes the relief of allergic symptoms, the prevention or control of nausea and vomiting, or the desired effect of inducing sedation or light sleep.

Q: What kind of patient monitoring or tests are typically recommended while on Fenazil?

For patients on prolonged treatment, labeling indicates that regular monitoring of the complete blood count (CBC) is generally advised. This monitoring helps detect rare but serious hematological reactions, such as agranulocytosis.

Q: Can Fenazil cause stomach upset or nausea, and if so, how is it typically managed?

Nausea and vomiting are listed side effects related to the use of Fenazil. Official instructions indicate that the oral forms of the medication may be taken with food, water, or milk to help mitigate potential gastrointestinal discomfort.

Q: Does Fenazil interact with caffeine or energy drinks?

Caffeine is known to be a stimulant, and it may counteract the sedative effects of Fenazil. Official sources note that excessive caffeine intake may be cautioned against.

Q: Why does the official documentation mention that certain groups should use Fenazil with caution?

Official caution is required because some individuals are more sensitive to the drug’s effects. The medication’s properties can increase the risk of severe sedation and confusion in older adults or worsen pre-existing conditions such as urinary tract blockage and cardiovascular disease.

How should Fenazil be stored and disposed of?

The official labeling for Fenazil (Promethazine hydrochloride) mandates strict environmental and handling rules to maintain product quality.

Storage Requirement Official Condition
Temperature Controlled Room Temperature (20 C to 25 C); permissible excursions to 30 C.
Protection Must be protected from light and kept from freezing (especially solutions) and excessive moisture.
Container Store in the original container and keep the container tightly closed.

All forms must be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired medication should be discarded following official guidelines, preferably through a drug take-back program or authorized collection site. The product is not recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fenazil found in:

A-Z Index: